21st Dec 2006 11:52
Akers Biosciences, Inc.21 December 2006 Akers Biosciences, Inc. ("Akers" or the "Company") Total Voting Rights In conformity with the Transparency Directive's transitional provision 6, wewould like to notify the market of the following: As at 21 December, the issued share capital and voting rights of the Company areas follows: Akers' share capital consists of 60,305,576 ordinary shares, nil par value, withvoting rights attached, one vote per ordinary shares. The above total voting rights figure may be used by shareholders as thedenominator for the calculations by which they will determine whether they arerequired to notify their interests in, or a change to their interest in, Akersunder the FSA's Disclosure and Transparency Rules. Contact Paul B. Freedman - 001 856 848 2116. END This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
AKR.L